305 related articles for article (PubMed ID: 16528972)
21. Total and lipid-bound serum sialic acid in children with malignancy or infections.
Romppanen J; Petäjä J; Heikinheimo M; Mononen I
Anticancer Res; 1998; 18(4B):2793-7. PubMed ID: 9713463
[TBL] [Abstract][Full Text] [Related]
22. Sialic acid levels in various types of cancer.
Kökoğlu E; Sönmez H; Uslu E; Uslu I
Cancer Biochem Biophys; 1992 Oct; 13(1):57-64. PubMed ID: 1343847
[TBL] [Abstract][Full Text] [Related]
23. Total and lipid-bound serum sialic acid in benign and malignant breast disease.
Romppanen J; Eskelinen M; Tikanoja S; Mononen I
Anticancer Res; 1997; 17(2B):1249-53. PubMed ID: 9137482
[TBL] [Abstract][Full Text] [Related]
24. Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease.
Serdar Z; Yeşilbursa D; Dirican M; Sarandöl E; Serdar A
Cell Biochem Funct; 2007; 25(6):655-64. PubMed ID: 17006879
[TBL] [Abstract][Full Text] [Related]
25. [Assessment of the selected, late phase of angiogenesis factors' concentration in colorectal cancer patients].
Wieloch M; Swiatkowska M; Libiszewski M; Hedayati M; Drozda R; Kołomecki K
Pol Merkur Lekarski; 2009 Dec; 27(162):466-9. PubMed ID: 20120708
[TBL] [Abstract][Full Text] [Related]
26. Preoperative plasma vascular endothelial growth factor but not nitrite is a useful complementary tumor marker in patients with colorectal cancer.
Tsai WS; Changchien CR; Yeh CY; Chen JS; Tang R; Chiang JM; Hsieh PS; Fan CW; Wang JY
Dis Colon Rectum; 2006 Jun; 49(6):883-94. PubMed ID: 16741643
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
Rajpura KB; Patel PS; Chawda JG; Shah RM
J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
[TBL] [Abstract][Full Text] [Related]
28. Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers.
Herszényi L; István G; Cardin R; De Paoli M; Plebani M; Tulassay Z; Farinati F
Eur J Cancer Prev; 2008 Oct; 17(5):438-45. PubMed ID: 18714186
[TBL] [Abstract][Full Text] [Related]
29. Serum level of cathepsin B and its density in men with prostate cancer as novel markers of disease progression.
Miyake H; Hara I; Eto H
Anticancer Res; 2004; 24(4):2573-7. PubMed ID: 15330217
[TBL] [Abstract][Full Text] [Related]
30. Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma.
Murnane MJ; Sheahan K; Ozdemirli M; Shuja S
Cancer Res; 1991 Feb; 51(4):1137-42. PubMed ID: 1997157
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic role of plasma and urinary sialic acid in human carcinoma of uterine cervix.
Balasubramaniyan N; Subramanian S; Sekar N; Bhuvarahamurthy V; Govindasamy S
Biochem Mol Biol Int; 1994 Jul; 33(4):617-23. PubMed ID: 7981648
[TBL] [Abstract][Full Text] [Related]
32. The effects of alcohol and smoking on serum, saliva, and urine sialic acid levels.
Kurtul N; Cil MY; Bakan E
Saudi Med J; 2004 Dec; 25(12):1839-44. PubMed ID: 15711651
[TBL] [Abstract][Full Text] [Related]
33. [Expression of cathepsin B and its clinical importance in colorectal cancer].
Yu B; Li SY; An P; Zuo FY; Cai HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):507-9. PubMed ID: 16299652
[TBL] [Abstract][Full Text] [Related]
34. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
Dabrowska B; Krasnodebski IW; Tadeusiak W
Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic usefulness of selected proteases and acute phase factors in patients with colorectal adenocarcinoma.
Sebzda T; Gnus J; Dziadkowiec B; Latka M; Gburek J
World J Gastroenterol; 2021 Oct; 27(39):6673-6688. PubMed ID: 34754160
[TBL] [Abstract][Full Text] [Related]
36. [Usefulness of sialic acid determination to differentiation between alcohol abuse and alcoholic liver cirrhosis].
Cylwik B; Brodowska D; Chrostek L; Panasiuk A; Szmitkowski M
Pol Merkur Lekarski; 2009 Nov; 27(161):368-71. PubMed ID: 19999798
[TBL] [Abstract][Full Text] [Related]
37. Increased TGF-beta 1 protein expression in patients with advanced colorectal cancer.
Langenskiöld M; Holmdahl L; Falk P; Angenete E; Ivarsson ML
J Surg Oncol; 2008 Apr; 97(5):409-15. PubMed ID: 18176914
[TBL] [Abstract][Full Text] [Related]
38. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
39. Sialic acid is an inflammation marker associated with a history of deep vein thrombosis.
Reganon E; Vila V; Martínez-Sales V; Vayá A; Mira Y; Ferrando F; Aznar J
Thromb Res; 2007; 119(1):73-8. PubMed ID: 16500696
[TBL] [Abstract][Full Text] [Related]
40. Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression.
Shimoyama S; Yamasaki K; Kawahara M; Kaminishi M
Clin Cancer Res; 1999 May; 5(5):1125-30. PubMed ID: 10353747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
